Mariola Fotin-Mleczek
Chief Tech/Sci/R&D Officer at CureVac SE
Profile
Dr. Mariola Fotin-Mleczek is a Chief Technology Officer at CureVac AG and a Chief Technology Officer at CureVac NV.
Mariola Fotin-Mleczek active positions
| Companies | Position | Start |
|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Chief Tech/Sci/R&D Officer | 2012-12-31 |
Former positions of Mariola Fotin-Mleczek
| Companies | Position | End |
|---|---|---|
| CUREVAC N.V. | Chief Tech/Sci/R&D Officer | 2022-01-30 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Private companies | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
- Stock Market
- Insiders
- Mariola Fotin-Mleczek
